Literature DB >> 26763847

What is the benefit of renal denervation?

Takuya Kishi1.   

Abstract

Mesh：

Year:  2016        PMID： 26763847     DOI： 10.1038/hr.2015.150

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  10 in total

Review 1.  Hormones and hemodynamics in heart failure.

Authors:  R W Schrier; W T Abraham
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

2.  Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design.

Authors:  Felix Mahfoud; Michael Böhm; Michel Azizi; Atul Pathak; Isabelle Durand Zaleski; Sebastian Ewen; Kostantinos Tsioufis; Bert Andersson; Peter J Blankestijn; Michel Burnier; Gilles Chatellier; Sameer Gafoor; Guido Grassi; Michael Joner; Sverre E Kjeldsen; Thomas Felix Lüscher; Melvin D Lobo; Chaim Lotan; Gianfranco Parati; Josep Redon; Luis Ruilope; Isabella Sudano; Christian Ukena; Evert van Leeuwen; Massimo Volpe; Stephan Windecker; Adam Witkowski; William Wijns; Thomas Zeller; Roland E Schmieder
Journal:  Eur Heart J       Date:  2015-05-18       Impact factor: 29.983

3.  Future of catheter-based renal denervation: key issues to solve.

Authors:  Genjiro Kimura
Journal:  Hypertens Res       Date:  2013-04-18       Impact factor: 3.872

4.  Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine β-hydroxylase inhibition with etamicastat.

Authors:  Nuno Miguel Pires; Bruno Igreja; Eduardo Moura; Lyndon Christopher Wright; Maria Paula Serrão; Patrício Soares-da-Silva
Journal:  Hypertens Res       Date:  2015-04-09       Impact factor: 3.872

Review 5.  Sympathetic nervous system overactivity and its role in the development of cardiovascular disease.

Authors:  Simon C Malpas
Journal:  Physiol Rev       Date:  2010-04       Impact factor: 37.312

6.  Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure.

Authors:  Sarah C Clayton; Karla K V Haack; Irving H Zucker
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-20

7.  Association between blood pressure and target organ damage in patients with chronic kidney disease and hypertension: results of the APrODiTe study.

Authors:  Ran-Hui Cha; Sejoong Kim; Sun Ae Yoon; Dong-Ryeol Ryu; Ji Eun Oh; Sang-Youb Han; Eun Young Lee; Dong Ki Kim; Yon Su Kim
Journal:  Hypertens Res       Date:  2013-09-19       Impact factor: 3.872

Review 8.  Renal denervation for the treatment of resistant hypertension: review and clinical perspective.

Authors:  Radu Iliescu; Thomas E Lohmeier; Ionut Tudorancea; Luke Laffin; George L Bakris
Journal:  Am J Physiol Renal Physiol       Date:  2015-07-29

9.  Renal denervation mitigates cardiac remodeling and renal damage in Dahl rats: a comparison with β-receptor blockade.

Authors:  Heitaro Watanabe; Yoshitaka Iwanaga; Yuki Miyaji; Hiromi Yamamoto; Shunichi Miyazaki
Journal:  Hypertens Res       Date:  2015-12-03       Impact factor: 3.872

Review 10.  Use of ambulatory blood pressure measurement in the definition of resistant hypertension: a review of the evidence.

Authors:  Alexandre Persu; Eoin O'Brien; Paolo Verdecchia
Journal:  Hypertens Res       Date:  2014-04-17       Impact factor: 3.872
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.